Stocks of Definitive Healthcare Corp. (NASDAQ:DH) traded higher last session on Wall Street, up 10.76% to $11.53.
According to the data, Definitive Healthcare Corp. (NASDAQ:DH) has 13 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $19.00 and a low of $11.00, we find $15.00. Given the previous closing price of $10.41, this indicates a potential upside of 44.09 percent. DH stock price is now -3.37% away from the 50-day moving average and -38.59% away from the 200-day moving average. The market capitalization of the company currently stands at $1.23B.
A total of 7 analysts have issued a hold rating and 5 have given it a buy rating. Brokers who have rated the stock have averaged $15.33 as their price target over the next twelve months.
With the price target of $13, BofA Securities recently initiated with Neutral rating for Definitive Healthcare Corp. (NASDAQ: DH). On July 06, 2022, Needham recently initiated its ‘Buy’ rating on the stock quoting a target price of $30, while ‘Credit Suisse’ rates the stock as ‘Neutral’.
In other news, Krantz Jason Ronald, Executive Chairman bought 450,000 shares of the company’s stock on Nov 07. The stock was bought for $5,193,000 at an average price of $11.54. Upon completion of the transaction, the Executive Chairman now directly owns 450,000 shares in the company, valued at $5.19 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 09, Director SEA VII Management, LLC sold 1,016,000 shares of the business’s stock. A total of $23,114,000 was realized by selling the stock at an average price of $22.75. This leaves the insider owning 2,508,971 shares of the company worth $28.93 million. Insiders disposed of 12,262,773 shares of company stock worth roughly $141.39 million over the past 1 year. A total of 1.80% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in DH stock. A new stake in Definitive Healthcare Corp. shares was purchased by T. ROWE PRICE INVESTMENT MANAGEMENT, INC. during the first quarter worth $14,631,000. ELEMENT CAPITAL MANAGEMENT LLC invested $4,539,000 in shares of DH during the first quarter. In the first quarter, RENAISSANCE TECHNOLOGIES LLC acquired a new stake in Definitive Healthcare Corp. valued at approximately $2,834,000. CITADEL ADVISORS LLC acquired a new stake in DH for approximately $2,408,000. CAAS CAPITAL MANAGEMENT LP purchased a new stake in DH valued at around $1,908,000 in the second quarter.
Monday’s opening bell rang with an opening price of $10.59 for Definitive Healthcare Corp. (NASDAQ: DH). During the past 12 months, Definitive Healthcare Corp. has had a low of $9.53 and a high of $30.11. As of last week, the company has a debt-to-equity ratio of 0.29, a current ratio of 3.30, and a quick ratio of 3.30. The fifty day moving average price for DH is $11.93 and a two-hundred day moving average price translates $18.77 for the stock.
The latest earnings results from Definitive Healthcare Corp. (NASDAQ: DH) was released for Jun, 2022. According to the Health Information Services Company, earnings per share came in at $0.06, beating analysts’ expectations of $0.05 by 0.01. This compares to -$0.24 EPS in the same period last year. The net profit margin was -12.60% and return on equity was -2.90% for DH. The company reported revenue of $57.38 million for the quarter, compared to $43.08 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 33.19 percent. For the current quarter, analysts expect DH to generate $56.64M in revenue.
Definitive Healthcare Corp.(DH) Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company’s platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.